July 28, 2026

• FDA Publishes Revised Draft Product-Specific Guidances for Certain Generic Peptide Products

July 24, 2026

• FDA approves zidesamtinib for ROS1-positive non-small cell lung cancer
• Notable Approval: FDA Approves First Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief

This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.